8-(4-Hydroxypiperidin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)-3,4-dihydroisoquinolin-1(2H)-one

ID: ALA4744768

PubChem CID: 147874387

Max Phase: Preclinical

Molecular Formula: C27H36N4O3

Molecular Weight: 464.61

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCC1Cc2cc(-n3nc(C)c4c3CC(C)(C)CC4=O)cc(N3CCC(O)CC3)c2C(=O)N1

Standard InChI:  InChI=1S/C27H36N4O3/c1-5-6-18-11-17-12-19(31-22-14-27(3,4)15-23(33)24(22)16(2)29-31)13-21(25(17)26(34)28-18)30-9-7-20(32)8-10-30/h12-13,18,20,32H,5-11,14-15H2,1-4H3,(H,28,34)

Standard InChI Key:  HZFRPINRGHBYHW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
   16.0489   -2.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6589   -2.8183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8349   -2.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7312   -4.4215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0123   -4.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3007   -4.4212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0116   -3.1809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5991   -1.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3442   -2.6970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4263   -1.9093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6801   -2.7014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4885   -2.8767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7952   -1.4708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9810   -1.2925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7282   -0.5072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1168   -1.2416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3098   -5.2432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5920   -5.6491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2996   -6.8935    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0180   -5.6579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0123   -6.4787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7164   -6.8917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4306   -6.4885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4363   -5.6677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7277   -5.2501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1416   -6.9069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8595   -6.5003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5706   -6.9187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8814   -5.2272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1657   -5.6296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1541   -6.4544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8643   -6.8753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5861   -6.4713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4332   -6.8541    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
 25  4  2  0
  4  5  1  0
  5  6  2  0
  6 17  1  0
  5  7  1  0
  7 11  1  0
 10  8  1  0
  8  9  2  0
  9  7  1  0
 10 11  2  0
 10 14  1  0
 11 12  1  0
 12  1  1  0
  1 13  1  0
 13 14  1  0
 14 15  2  0
  8 16  1  0
 21 19  2  0
 20 17  2  0
 17 18  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
 26 27  1  0
 27 28  1  0
 18 29  1  0
 18 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 31 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4744768

    ---

Associated Targets(Human)

HSP90AB1 Tchem Heat shock protein HSP 90-beta (1689 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP90AA1 Tchem Heat shock protein HSP 90-alpha (4115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.61Molecular Weight (Monoisotopic): 464.2787AlogP: 3.75#Rotatable Bonds: 4
Polar Surface Area: 87.46Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.05CX LogP: 2.77CX LogD: 2.77
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.72Np Likeness Score: -0.20

References

1. Mishra SJ,Liu W,Beebe K,Banerjee M,Kent CN,Munthali V,Koren J,Taylor JA,Neckers LM,Holzbeierlein J,Blagg BSJ.  (2021)  The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition.,  64  (3.0): [PMID:33428418] [10.1021/acs.jmedchem.0c01700]

Source